Wound Repair

Capabilities

Kensey Nash’s proprietary OPTRIX™ process is used to make extracellular matrix products that aid in wound healing by providing a biologic scaffold that supports the body’s natural healing process. By removing antigenic components while maintaining the native collagen structure and extracellular matrix biomolecules, the OPTRIX™ process results in an innovative line of tissue regeneration products that provide the ideal environment for cell infiltration and revascularization.

Chronic and Acute Wound Treatment

Potential applications include:

• Partial and full thickness wounds
• Diabetic ulcers
• Venous ulcers
• Pressure ulcers
• Post surgical wounds
• Trauma wounds
• Second degree burns

Technology

• Extracellular Matrices Technology

This page is not intended to promote the use of the product in these applications but to suggest the possible clinical applications for which regulatory approvals can be sought. OPTRIX is a trademark of Kensey Nash Corporation.